title: Perspectives on drug-induced vascular injury.
authors.affiliation: Pfizer Inc., Cambridge, Massachusetts, USA dan.g.morton@pfizer.com.
authors.forename: Daniel
authors.initials: D
authors.lastname: Morton
authors.affiliation: Pfizer Inc., Groton, Connecticut, USA.
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Houle
authors.affiliation: Pfizer Inc., Cambridge, Massachusetts, USA.
authors.forename: Lindsay
authors.initials: L
authors.lastname: Tomlinson
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000962:Antimalarials / Q000009:adverse effects; D000998:Antiviral Agents / Q000009:adverse effects; D006801:Humans; D057772:Vascular System Injuries / Q000139:chemically induced* / Q000473:pathology*
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D000998:Antiviral Agents